2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
Cardiovascular complications in hematopoietic stem cell transplanted patients
Y Zhao, R He, S Oerther, W Zhou, M Vosough… - Journal of Personalized …, 2022 - mdpi.com
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for many
patients suffering from hematologic malignancies, solid tumors, inborn errors of metabolism …
patients suffering from hematologic malignancies, solid tumors, inborn errors of metabolism …
2022 ACC/AHA/HFSA guideline for the management of heart failure
ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for many
malignancies, hemoglobinopathies, metabolic diseases, bone marrow failure syndromes …
malignancies, hemoglobinopathies, metabolic diseases, bone marrow failure syndromes …
Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation
The purpose of this review is to provide a framework for the cardiovascular evaluation and
management of patients undergoing hematopoietic cell transplantation (HCT). To …
management of patients undergoing hematopoietic cell transplantation (HCT). To …
Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome
J Li, MH Duan, C Wang, XF Huang, W Zhang, XX Cao… - Leukemia, 2017 - nature.com
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal
gammopathy and skin changes) is a rare plasma cell dyscrasia sometimes treated with a …
gammopathy and skin changes) is a rare plasma cell dyscrasia sometimes treated with a …
Cardiovascular diseases in patients after hematopoietic stem cell transplantation: Systematic review and Meta-analysis
A Alizadehasl, N Ghadimi, H Hosseinifard… - Current Research in …, 2023 - Elsevier
Abstract Background Hematopoietic Stem Cell Transplantation (HSCT), is performed to treat
many malignancies such as autologous or allogenic. Despite the success of this method in …
many malignancies such as autologous or allogenic. Despite the success of this method in …
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From …
Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular
risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular …
risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular …
Cardiotoxicity in hematopoietic stem cell transplant: keeping the beat
JK Baker, J Shank-Coviello, B Zhou, J Dixon… - … Myeloma and Leukemia, 2020 - Elsevier
Introduction The number of hematopoietic stem cell transplants (HSCTs) performed in the
United States and worldwide is increasing. Cardiac events have been well described in …
United States and worldwide is increasing. Cardiac events have been well described in …
Cardiovascular toxicity from therapies for light chain amyloidosis
Amyloid light-chain (AL) amyloidosis is a hematological disorder characterized by abnormal
proliferation of a plasma cell clone producing monoclonal free light chains that misfold and …
proliferation of a plasma cell clone producing monoclonal free light chains that misfold and …